Background: Endothelin-1 (ET-1) is a multifunctional peptide, which is implicated in the renal and cardiac physicology as well as in many pathologies of these systems. ET-1's actions take place after the activation of two receptors: ET A and ET B . The expression of these receptors may be modulated during the pathologic process. The analysis of the distribution and level of expression of the receptors in animal models is therefore crucial. Methods: We developed a protocol for non-radioactive in situ hybridization for the mRNA of the two endothelin receptors on paraffin-embedded tissue using digoxigenin-labeled RNA probes. Results: In heart and kidney, the staining was reliable and specific. In a mouse model for endothelin/nitric oxide imbalance, cardiac ET B expression was reduced. The distribution of the receptors was in accordance with the actual knowledge. Differences in cell specific expression are discussed. Conclusions: We developed a protocol for the in situ hybridization of the endothelin receptors in mice. Given that the endothelin system is implicated in the development of many diseases, we believe that this protocol may be useful for a number of future preclinical studies.. (Clin. Lab. 2012;58:939-949.
INTRODUCTION
Endothelin-1 (ET-1) is a multifunctional peptide which modulates plethoric cellular and physiological functions. Particularly in the cardiac and renal systems, the importance of ET-1 is acknowledged also in the development of numerous pathologies [1] . The cellular response to ET-1 is complex and is modulated by several factors, particularly nitric oxide which can be considered as the functional antagonist. We previously crossbred mice to obtain animals with an overexpression of ET-1 and endothelial NO synthase deficiency (ET+/+eNOS-/-) [2] . Given that a reduced nitric oxide production and bioavailability combined with an elevation of ET-1 expression is a frequent finding in heart failure and kidney disease patients [3, 4] , these mice represent a valuable tool for the understanding of the ET-1 system and its implication in pathologies. ET-1 is a paracrine and autocrine hormone with low serum concentration. The localization of the receptors A and B (ET A and ET B ) is widespread in both the heart and the kidney. Nevertheless, in the kidney particularly, the type of cell which expresses each receptor remains disputed. The activation of these receptors induces various intracellular pathways, which can be contradictory in terms of functional response depending on the receptor type, cell type, and physiological situation. Moreover, the expression of the receptors is modified in pathological situations [5] . It is therefore crucial to possess a reliable tool to assess the distribution and level of expression of the receptors. We propose here a protocol for non-radioactive, in situ hybridization of the two endothelin receptors on paraffin-embedded tissue. The preparation of the digoxigenin-labeled RNA probes and ____________________________________________ Manuscript accepted March 3, 2012 the staining are presented in detail. This protocol is optimized for the mouse sample, the most standard animal model used nowadays.
MATERIALS AND METHODS

Mice
We used 9-month-old ET+/+eNOS-/-mice and wildtype mice [6] .
In situ hybridization
ETA and ETB cloning
For the production of the RNA probes needed for the in situ hybridization, sections of the ET A and ET B genes have been cloned in an expression vector. Primers for the cloning of ET A and ET B were designed using Primer3 and the sequences from the Ensembl Database143 as templates (ET A : Ensembl Transcript ENSMUST000 00034029, ET B : Ensembl Transcript ENSMUST000 00022718). The forward and reverse primers were flanked with the restriction sites of Bsu15I and BcuI, respectively, and the GAT sequence as spacer (Table 1) . Amplification by PCR of the corresponding sequence was performed using mouse cDNA as template. The PCR was performed with 0.02 u/µL Phusion DNA Polymerase (F-530, Finnzymes) in Phusion HF buffer with the addition of 200 μM of each dNTP, 3% (v/v) DMSO, and 0.5 μM of each primer, using the following protocol: initial denaturation at 98°C, 30 seconds; 30 cycles: denaturation at 98°C, 20 seconds; annealing at 63°C, 30 seconds; elongation at 72°C, 30 seconds; final elongation at 72°C, 10 minutes. The DNA fragment was separated on a 1% low melt agarose/0.1% ethidium bromide gel and the size of the amplicon was checked. The band was excised from the gel and the DNA was extracted using the gel extraction kit QIAquick (28704, Qiagen). The DNA fragments as well as the pBluescript KS (-) expression vector (#21220, Stratagene) were cut using 20 u Bsu15I (ER0141, fermentas) and 20 u BcuI (ER12 51, fermentas) for 2 hours at 37°C followed by heat inactivation at 65°C for 20 minutes. 100 ng of the fragments were ligated in the presence of pBluescript vector using 2 u of T4 ligase (EL0015, fermentas) in appropriate buffer overnight at 16°C. The correct insertion of the fragment was verified by separation of the plasmid obtained after digestion with EcoRV (ER0301, fermentas) on agarose gel. Chemically competent Oneshot Top10 E. coli cells (C4040, Invitrogen) were transformed as recommended by the provider with 2 μL vector solution, incubated 30 minutes on ice, 30 seconds at 42°C and then put on ice again. The cells were then supplemented with 250 μL LB medium and incubated 1 hour at 37°C on a shaker and finally plated on LB Agar/Xgal 20 µg/mL/IPTG 0.1 mM. Positive colonies were picked and cultivated overnight in 5 mL LB medium. The plasmid was extracted and an aliquot of the culture was stored at -80°C in glycerol.
RNA probes production
Plasmid extraction was done using a plasmid extraction kit (NucleoSpin Plasmid 740588, Macherey-Nagel). The plasmid was linearized with 0.5 u/μL of either BcuI or Bsu15I restriction enzyme in corresponding buffer for 2 hours at 37°C for T3 or T7 RNA polymerase in order to produce the anti-sense and sense probes, respecttively. DNA was then precipitated and washed with SureClean (BIO-37047, Bioline) and resuspended in water. The labeled RNA probe was produced using a DIG labeling kit (11 175 033 910, Roche). 1 μg DNA was incubated with 1x DIG labeling dNTP mix, 10 mM DTT, 20 u/μL RNAse inhibitor (rRNAsin, Promega) and 1 u/μL T3 or T7 RNA Polymerase in the appropriate buffer for 2 hours at 37°C. DNA was then digested with 1 μL DNAse I (18047-019, Invitrogen) for 15 minutes at 37°C. RNA was washed with EtOH70%/LiCl 0.1M and incubated 30 minutes at -80°C. The probe was resuspended in water and its concentration was measured by spectrophotometry.
Staining protocol
The in situ hybridization was performed on 5 μm thin heart and kidney paraffin slices. The following steps were performed by pipetting 600 μL on the slice. The RNA probes were denaturated 5 minutes at 85°C before diluting to 1 μg/mL in hybridization buffer. Negative controls were run in every experiment by using the sense RNA probe. On the first day, the slices were rehydrated by incubating them three times 10 minutes in xylol 100% at RT, and in EtOH 95%, EtOH 90% , EtOH 90%, EtOH 80%, EtOH 70%, EtOH 50%, EtOH 30% for 1 minute each at RT. Slides were washed twice in PBS and incubated in PBS 4% PFA for 30 minutes at RT and then washed again. The slides were incubated in Proteinase K for 10 minutes at RT (20 mM Tris-HCl, 1 mM EDTA, 10 μg/mL Proteinase K (Sigma), pH 7.2), washed, and fixed again in PBS 4% PFA for 30 minutes at RT and washed. The slides were then incubated in 2 x SSC for 2 minutes at RT (0.3 M NaCl, 30 mM Nacitrate x 2H2O, pH 7.0), then in 10 mM Tris Base, 100 mM glycine, pH 7.0 30 minutes at RT and finally washed. Slides were incubated in acetylation buffer (1.2% (w/v) Triethanolamine, 0.25% (v/v) acetic anhydride) for 10 minutes at RT and washed. The hybridisation buffer was as follow: 50% (v/v) formamide, 5 x SSC, 5 x Denhardts (50 x Denhardts: 1% (w/v) BSA, 1% (w/v) Ficoll, 1% (w/v) PVP), 200 μg/mL tRNA (S.cerevisiae, Sigma), 100 μg/mL Heringssperma (Sigma). Slices were incubated for 4 hours at RT in hybridization buffer and 16 hours at 70°C in a chamber humidified with 2 x SSC solution buffer. On the second day, the slides were incubated in 5 x SSC for 20 minutes at RT, three times. The following steps were performed in a chamber humidified with 2 x SSC solution: 20% (v/v) Formamide, 0.5 x SSC for 40 minutes at 60°C and 90 minutes at 37°C; NTE-buffer (0.5 M NaCl, 0.5 mM EDTA, 10 mM Tris-HCl pH 7.0) for 15 minutes at 37°C; RNAse A 40 μg/mL 30 minutes at 37°C in NTE-buffer and again NTE-buffer for 15 minutes at 37°C. The slides were incubated again in formamide solution for 40 minutes at 60°C and washed twice for 15 minutes at RT in 2 x SSC. The staining was as follow: two incubations in buffer 1 (0.1 M maleic acid, 0.15 M NaCl, pH 7.5) for 5 minutes at RT. Unspecific sites were blocked for 1 hour at RT with blocking solution (1% (w/v) blocking reagent (Boehringer) and 1% (v/v) Tween20 in buffer 1). The anti-DIG antibody was diluted 1/400 in blocking solution and incubated for 1 hour at RT. The slides were washed twice for 30 minutes with buffer 1. After incubation for 5 minutes in buffer 2 (100 mM NaCl, 50 mM MgCl 2 , 100 mM TrisHCl pH 9.5, 0.1% (v/v) Tween20), the substrate was added (buffer 3: 0.55 mM NBT, 0.4 mM BCIP in buffer 2) for 3 hours. The slides were washed twice for 10 minutes in TE-buffer (1 mM Tris, 1 mM EDTA, pH 8.0), in PBS for 30 minutes, and finally in water for 5 minutes. At the end, the slices were mounted with Hydromount (HS-106, National Diagnostics).
Relative quantification
Slices were photographed under a light microscope (magnification x 200) and saved as jpeg pictures at 150 dpi, RBG 24 bits. Consecutive pictures were taken to cover the whole left cardiac ventricle. Using ImageJ, the pictures were converted into 8 bit grey scale pictures. The signal was measured using the threshold function defined manually on a randomly chosen set of pictures. Once the threshold for segregating the signal from background was chosen, all pictures were analysed in the same way. A second threshold was used to measure the tissue area from each picture. The final signal was defined as a signal percentage from the tissue area. Negative control pictures were analysed using the same thresholds.
Western blot
Snap frozen hearts were pulverized with mortar and pestle under liquid nitrogen. The powder was dissolved in 600 μL lysis buffer (Tris/HCl 25 mM, KCl 50 mM, EDTA 3 mM, benzamidine 2.9 mM, leupeptin, 2.1 μM, urea 7 M, thiourea 2 M, DTT 70 mM) for 100 mg of tissue. The samples were vortexed and incubated for 10 minutes at room temperature and then centrifuged for 45 minutes at 13000 rpm at 20°C. The supernatants were collected, aliquoted, and stored at -20°C. The protein solution (25 μg) was heated 1 minute at 95°C in the presence of loading buffer (K929.1, Roth) before loading on an SDS-PAGE gel 10% acrylamide. Fermentas) on every gel. Hydrophobic polyvinylidene difluoride (PVDF) (Amersham Hybond-P, RPN303F, GE Healthcare) membrane was activated for 1 minute in methanol and incubated as along with the transfer paper and the gel in transfer buffer (methanol 20%, glycine 175 mM, 32 mM Tris). The proteins were transferred onto the PVDF membrane overnight at 4°C under 5 V tension using semidry transferring equipment (TransBlot SD, BioRad). The unspecific sites were blocked one hour with Tris buffered saline (TBS) (20 mM Tris, 140 mM NaCl, pH 7.6), Tween-20 0.1%, milk 5%. The primary antibodies anti-ET A (sc33536, Santacruz) anti-ET B (sc33538, Santacruz), and βactin (sc1615, Santacruz) were diluted in TBS-Tween milk 4% and incubated overnight at 4°C. The horseradish peroxidase coupled anti-rabbit immunoglobulin secondary antibody (NA934V, Amersham Biosciences) was diluted 1/5000 in TBS-T 4% BSA one hour at RT. Between each detection, the membrane was stripped by incubation with glycine 25 mM/SDS 1% (pH 2) for 30 minutes at 50°C. Every incubation was preceded by three washes with TBS Tween for 10 minutes. Immunoreactive sites were visualized using a chemiluminescence detection system (ECL Mix . Membranes were exposed to autoradiography film (8194540, Kodak BioMax Light Film), developed on a developer (Curix 60, Agfa), and finally scanned at 300 dpi as 24 bit 256 greyscale pictures on a Canon scanner (Canoscan 5000F, Canon). The band intensity was measured using the AlphaEaseFC software (Alpha Innotech) for densitometry. The intensity of each sample was first normalized to a standard curve loaded an each gel and then normalized to the intensity of β-actin.
Statistical analysis
The differences in signal intensity between the groups were analysed using the non-parametric Mann-Whitney U-test. A p value lower than 0.05 was considered as significant.
RESULTS
Endothelin receptors in the heart
The two endothelin receptors were found to be expressed in cardiomyocytes as well as in the cardiac vessels (Figure 1 ). No differences were observed concerning the localization of ET A and ET B between the groups. Relative quantification of the signal showed that ET B , but not ET A was less expressed in the myocardium of ET+/+eNOS-/-mice compared to WT mice (Figure 1 ). In the vessels, however, it appeared that ET B expression was similar in both groups (Figure 1) . A negative control using the sense RNA probe confirmed the specificity of the staining. Western blot analysis showed that the ET A expression was similar between the groups (Figure 2 ) while ET B expression was reduced in ET+/+eNOS-/-compared to WT mice also at the protein level, thereby confirming the in situ hybridization data. 
Endothelin receptors in the kidney
Both ET A and ET B are relatively more representated in the medulla than in the cortex ( Figure 3A , 4A, 5A, 6A). In the cortical glomeruli, both ET A and ET B are expressed in podocytes ( Figure 3C , 4C, 4G, 5C, 6F). The distal convoluted tubule (DCT) was easily recognized by its relatively bigger lumen compared to the proximal convoluted tubule (PCT) and its epithelial cells with smaller cytoplasm. Moreover, the lumen of PCT is typically almost filled by the apical brush border. ET A and ET B were expressed in DCT and PCT. The signal was however much stronger in DCT than PCT ( Figure 3C , 4C, 4G, 5C, 6F). Concerning ET A , this difference seemed accentuated in ET+/+eNOS-/-mice compared to WT mice ( Figure 5C ). The connecting tubules are an additional site of endothelin receptor expression in the cortex ( Figure 3D, 4F, 6C ). In the distal straight tubule or thick ascending limb of the Henle's loop (TAL), expression of the endothelin receptors could be visualized ( Figure 3E, 4A, 5D, 6D ). The inner medullary collecting duct (imCD) ( Figure 3K , 4I, 5K, 6J) as well as the Henle's loop ( Figure 3J , 4I, 5I, 6K) express the endothelin receptors. Finally, in the vasa recta, ET A mRNA was present in the pericytes ( Figure 3I -K, 5K-L). The staining for ET B in the vasa recta was more continuous indicating an expression in the endothelial cells ( Figure  4I , 6I). 
DISCUSSION
In order to accurately analyse the complex effects of ET-1 or its antagonists in preclinical studies, it is important to localize the site of expression of its receptors. The use of antibodies for the localization of the endothelin receptors in the kidney led to disputed results. For instance, even though a functional ET A has been demonstrated in the thin descending limb of the rat [7] , immuno-histochemical studies showed no receptor expression at all in this part of the nephron [8, 9] . The specificity of antibodies is often difficult to confirm; the expression mapping using in situ hybridization therefore offers a more specific alternative. The absence of signal using the sense RNA probes as negative control showed the specificity of the probes developed in our laboratory.
In the heart, we could show that ET B mRNA expression is lower in the ET+/+eNOS-/-mice compared to WT mice. This result has been confirmed at the protein level by western blotting, which is a confirmation of the specificity of our RNA probes. In contrast to Terada et al. [10] , we have detected ET B mRNA in the proximal tubule. Our results are supported by several studies which described a functional ET B is the proximal tubule [11] . Using immunostaining, Wendel et al. could observe only ET B is this part. Nevertheless, both receptors seem to be expressed in the human proximal tubule, which is in line with our observations [12] . In the medullary thick ascending limb, we have shown ET B mRNA expression ( Figure 6K ), which has been already observed [10] . This result was confirmed at the level of protein abundance by immunofluorescence [13] . Even though ET B has been shown to be the only endothelin receptor in the ascending limbs using antibodies [13] , with our protocol, we could get a positive signal for ET A in this part. The mRNA expression may not translate into a functional protein in this case. Moreover, based on our study, it was evident that mRNA expression of endothelin receptors was stronger in the distal convoluted tubules than in the proximal ones. In the rat thin limb of Henle's loop, reverse transcripttion PCR experiments revealed the presence of ET A and ET B mRNA [14] , which our observations corroborate. We detected strong expression of both receptors in the collecting duct. A significant presence of ET B in the cortical and inner-medullary collecting duct has been proven before both at the mRNA and protein level [15, 16] . These observations were confirmed later by functional analysis [17] . ET A is reportedly expressed in the collecting duct as well [18, 19] . Based on these studies, ET B is the predominant receptor in the collecting duct. In our setting, however, the strength of the signal for both receptors was similar. The glomerulus is a site of ET-1 binding and expression of both endothelin receptors [20] . In the glomerular epithelial cells, or podocytes, we observed a positive signal using both ET A and ET B mRNA probes, which confirms previous studies [21, 22, 23, 24] .
In conclusion, we have developed a reliable protocol for the in situ hybridization of the endothelin receptors. The endothelin receptors are implicated in many systems such as the renal, cardiovascular, and pulmonary systems and also the reproductive and nervous systems. We therefore believe that this protocol may be useful for a number of future preclinical studies.
